claim: fda authorizes first next generation sequence test for diagnosing covid-19
evidence_1: the fda authorized the illumina covidseq test for the qualitative detection of sars-cov-2 rna from respiratory specimens collected from individuals suspected of covid-19 by their healthcare provider.